1. Home
  2. RGNX vs IVR Comparison

RGNX vs IVR Comparison

Compare RGNX & IVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • IVR
  • Stock Information
  • Founded
  • RGNX 2008
  • IVR 2008
  • Country
  • RGNX United States
  • IVR United States
  • Employees
  • RGNX N/A
  • IVR N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • IVR Real Estate Investment Trusts
  • Sector
  • RGNX Health Care
  • IVR Real Estate
  • Exchange
  • RGNX Nasdaq
  • IVR Nasdaq
  • Market Cap
  • RGNX 424.8M
  • IVR 493.9M
  • IPO Year
  • RGNX 2015
  • IVR 2009
  • Fundamental
  • Price
  • RGNX $8.17
  • IVR $7.55
  • Analyst Decision
  • RGNX Strong Buy
  • IVR Hold
  • Analyst Count
  • RGNX 8
  • IVR 3
  • Target Price
  • RGNX $31.75
  • IVR $7.25
  • AVG Volume (30 Days)
  • RGNX 542.3K
  • IVR 1.8M
  • Earning Date
  • RGNX 08-07-2025
  • IVR 07-24-2025
  • Dividend Yield
  • RGNX N/A
  • IVR 17.99%
  • EPS Growth
  • RGNX N/A
  • IVR N/A
  • EPS
  • RGNX N/A
  • IVR 0.32
  • Revenue
  • RGNX $156,718,000.00
  • IVR $59,701,000.00
  • Revenue This Year
  • RGNX $327.08
  • IVR $278.42
  • Revenue Next Year
  • RGNX N/A
  • IVR N/A
  • P/E Ratio
  • RGNX N/A
  • IVR $23.70
  • Revenue Growth
  • RGNX 80.70
  • IVR 1793.56
  • 52 Week Low
  • RGNX $5.04
  • IVR $5.86
  • 52 Week High
  • RGNX $13.48
  • IVR $9.42
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 45.17
  • IVR 47.27
  • Support Level
  • RGNX $8.27
  • IVR $7.50
  • Resistance Level
  • RGNX $9.32
  • IVR $7.80
  • Average True Range (ATR)
  • RGNX 0.49
  • IVR 0.17
  • MACD
  • RGNX -0.04
  • IVR 0.01
  • Stochastic Oscillator
  • RGNX 20.16
  • IVR 58.83

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About IVR INVESCO MORTGAGE CAPITAL INC

Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.

Share on Social Networks: